Alpine Immune Sciences, Inc. Gains 124.85%
Thu, Jun 18, 2020 at 05:30 PM
Alpine Immune Sciences, Inc. (ALPN:NASDAQ) jumped higher at $10.95, a gain of 124.8%. On Wed 17 Jun 20, ALPN:NASDAQ touched a New 2-Week High of $4.87. The stock got featured on our News Catalysts scanner on Thu 18 Jun 20 at 02:47 PM in the 'MISCELLANEOUS' category. From Wed 03 Jun 20, the stock recorded 40.00% Up Days and 45.45% Green Days
About Alpine Immune Sciences, Inc. (ALPN:NASDAQ)
Nivalis Therapeutics Inc a pharmaceutical company, focuses on the discovery and development of product candidates for patients with cystic fibrosis. Geographically operation of the group is functioned through United States.
Top 10 Gainers:
- Alpine Immune Sciences, Inc. (ALPN:NASDAQ), 124.85%
- Urban One, Inc. (UONE:NASDAQ), 96.7%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 89.36%
- Neonode Inc. (NEON:NASDAQ), 69.02%
- Farmmi, Inc. (FAMI:NASDAQ), 58.38%
- Nuverra Environmental Solutions, Inc. (NES:NYSEMKT), 53.68%
- Carver Bancorp, Inc. (CARV:NASDAQ), 48.99%
- HUSN (HUSN:NASDAQ), 48.43%
- Biocept, Inc. (BIOC:NASDAQ), 47.2%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 41.16%